** Dermatology firm Galderma's GALD.S stock is seen up 3.65% in Julius Baer premarket indications after the French cosmetics group L'Oreal OREP.PA said it would increase its stake in the Swiss company to 20%
** L'Oreal will buy the stake for an undisclosed sum from a consortium led by Swedish private equity firm EQT EQTAB.ST, with the deal due to close in the first quarter of 2026
** "The continuous build-up of L'Oréal's stake in Galderma reduces the number of shares still held by private equity investors that eventually search for an exit," Vontobel ("buy") writes
** Galderma's stock is up around 62% year-to-date
(Reporting by Tristan Veyet)
((tristan.chabba@thomsonreuters.com))